CUSIP N71542109SHS EUROQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
64 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Adage Capital Partners Gp, L.L.C. | 6.25M | $12.63M | 0 | Held |
| 2 | Privium Fund Management B.V. | 5.36M | $10.82M | +359.5K | Added |
| 3 | Aberdeen Group PLC | 2.95M | $5.96M | +651.9K | Added |
| 4 | Affinity Asset Advisors, LLC | 2.45M | $4.96M |
| −1.15M |
| Reduced |
| 5 | Sio Capital Management, LLC | 2.16M | $4.37M | +89.0K | Added |
| 6 | Dafna Capital Management LLC | 1.57M | $3.17M | 0 | Held |
| 7 | Kynam Capital Management, LP | 1.57M | $3.16M | −83.1K | Reduced |
| 8 | Ikarian Capital, LLC | 1.49M | $3.01M | +600.0K | Added |
| 9 | Morgan Stanley | 1.37M | $2.76M | −1.53M | Reduced |
| 10 | Platinum Investment Management Ltd | 1.24M | $2.50M | 0 | Held |
See every fund holding Proqr Thrapeutics N V, with full quarter-over-quarter share changes.
Unlock all holders